Login

Company Executives

$ Management Team

Dr. Gerald Chan

Independent Chairman of the Board

Age 74
Compensation $498.7K USD
Sex Male

Dr. Cedric Francois

President

Chief Executive Officer

Co-Founder

Director

Age 52
Compensation $10.96M USD
Sex Male

Dr. Pascal Deschatelets

Co-Founder

Chief Scientific Officer

Age 55
Compensation $3.082M USD
Sex Male

Mr. Timothy Sullivan

Chief Financial Officer

Treasurer

Age 54
Compensation $3.949M USD
Sex Male

Ms. Nur Nicholson

Chief Technical Operations Officer

Age 56
Compensation $3.022M USD
Sex Female

Mr. James Chopas

Vice President

Corporate Controller

Chief Accounting Officer

Age 58
Compensation -
Sex Male

Mr. David Watson

General Counsel

Secretary

Age 52
Compensation $3.892M USD
Sex Male

Dr. Caroline Baumal

Chief Medical Officer

Age 58
Compensation $4.407M USD
Sex Female

Mr. Mark Delong

Chief Business and Strategy Officer

Age 48
Compensation -
Sex Male

Mr. Niel Carnahan

Investor Contact

Age -
Compensation -
Sex Male
Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
9.5 years
from year joined
CEO also chairs the board
No
Gerald Chan
Director Age On board Independent Committees Other public boards Pay Source
A. Sinclair Dunlop
53 2010
15 years
Independent None stated None stated Not stated
Alec Machiels
52 2009
16 years
Independent
Audit · Chair
None stated Not stated
Keli Walbert
58 2025
0 years
Independent
Compensation
None stated Not stated
Paul Fonteyne
63 2020
5 years
Independent
Compliance · Chair
Amylyx Pharmaceuticals, Inc. Not stated
Stephanie Monaghan O’Brien
66 2013
12 years
Independent
Compensation · Chair
None stated Not stated
Gerald Chan
74 2013
12 years
Independent
Nominating and Corporate Governance · Chair
Hang Lung Group Limited Not stated
Cedric Francois
52 2009
16 years
Not independent None stated None stated Paid as CEO
Craig Wheeler
63 2025
0 years
Independent
Audit
Amicus Therapeutics, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support